We found that the PW treatment was able to reduce the LPS-induced lung inflammation by decreasing the total cell and neutrophil counts in the BALF (Figures 7B, C) and increasing the anti-inflammatory cytokine IL-10 in the BALF (Figure 7D), and reducing the ratio of wet-to-dry lung (W/D ratio) indicating the severity of pulmonary edema (Figure 7E). The gene discussed is IL10; the disease is edema.